Opening of Adamed’s new office in Uzbekistan

In early October, Adamed’s office in Tashkent was officially opened in a new location. The opening ceremony was attended by representatives of diplomacy, public administration, and the academia. The new headquarters reflects Adamed’s growth and development in the Uzbek market.

Central Asia is an important direction of growth and overseas expansion for Adamed Pharma. Through its representative office, the company has been present in Uzbekistan since 2020, continuously expanding its activities in the region. The relocation to a new office was another step in Adamed’s development aligned with the implementation of the company’s growth plan in Asia.

“This is a very important day for the entire Adamed community. The opening of Adamed’s new office in Uzbekistan is a new milestone on the company’s journey towards building a strong position in this market, also from the prospect of future investments. We are planning to add 20 innovative cardiac medications to the portfolio of products offered in the region. This is how we respond to the needs and support patients and physicians in the fight against cardiovascular diseases. It is a step towards long-term fruitful cooperation between Poland and Uzbekistan in the implementation of a drug policy based on safety and innovation”, said Sylwia Berdzik-Kalarus, Member of the Management Board at Adamed Pharma S.A. and Director of Commercial Affairs and Business Development.

The ceremony was attended by Radosław Gruk, Ambassador of the Republic of Poland in Uzbekistan and Tajikistan, who joined the company’s representatives for the official opening of the new headquarters.